Ignis Therapeutics

About:

Ignis Therapeutics is a innovative therapies in the field of central nervous system.

Top Investors: Goldman Sachs, KB Investment, Mubadala Energy, 6 Dimensions Capital, HBM Healthcare Investments

Description:

Ignis Therapeutics is a life science company developing innovative therapies in the field of the central nervous system. With a strong commitment to self-discovery and a development strategy to advance the treatment paradigm, Ignis Therapeutics transforms the approach to treating CNS conditions. Ignis Therapeutics is dedicated to developing products that significantly improve the lives of patients while also providing additional therapeutic options for physicians.

Total Funding Amount:

$183M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2019-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2023-01-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai